Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
MRSA
Research
Infinity Pharma cancer drug stops COVID, MRSA damage in mice
New findings in mice show that an experimental cancer drug developed by a now-bankrupt biotech can suppress a key driver of lung inflammation.
Helen Floersh
Jul 9, 2024 7:00am
GSK drops celiac disease program acquired in Sitari buyout
Feb 1, 2023 6:40am
'Uninterpretable' phase 3 results stymie ContraFect
Dec 20, 2022 1:18pm
ContraFect halts phase 3 after antimicrobial fails futility test
Jul 14, 2022 10:35am
Fighting superbugs with ‘supercharged’ antibiotics
Jan 8, 2018 9:40am
Fighting antibiotic resistance with human-germ hybrids
Apr 17, 2017 3:48pm
